CD107a-, IFNγ- and MIP 1β-producing Vγ9Vδ2 T-cell subsets decrease in HIV+ patients. by Rita Casetti (608635)

Fig 5 - by Dennis Ochola (11626912)

Conditional PyLT expression induces cell cycle progression, an increase in cyclin A and a decrease in p21 in ICI treated cells. by Hemant Varma (30590)

Foxo1 decreases <i>SCN5a</i> promoter activity. by Weike Mao (181121)

Nicotine decreased Wnt5a expressions in SK-BR-3 cells. by Masanori A. Murayama (5774585)

CPZ decreases K⁺-dependent Na⁺, K⁺-ATPase transport activity. by Yasser A. Mahmmoud (562155)

A decrease in circulating CXCR5+CD4+ Tfh cells is associated with HCC progression, and CXCR5+CD4+ Tfh cells are decreased in tumor regions. by Yiqiong Jia (692871)

“…<p>(A) The prevalence of CXCR5+CD4+ Tfh cells decreases with progressive stages in HCC. …”

Effect sizes (if > 0.5) for the comparison of increasing load vs. decreasing for the iliocostalis muscle. by Christoph Anders (4068499)

Increased expression of Fz5 receptor matched with a decrease in NeuN immunoreactivity at 16w. by Carlos González-Fernández (2794207)

A prepubertal CD decreases hepatic DNA methylation and increases hydroxymethylation in adulthood despite a chronic HFD in Sprague-Dawley male rats. by Ana Aguilar-Lozano (20614619)

(A) The temperature sensitive allele of <i>HEM1</i> leads to a significant decrease in the endogenous levels of Cia2 and Mms19. by Ifat Lev (469072)

Colored points represent the dates where events from Fig 7, have a <i>p</i>-value below the <i>α</i> = 0.05 significance level, i.e. dates where the statistical behavior of the dur... by Héctor Raúl Olivares-Sánchez (13014866)

Table_1_A phased intervention bundle to decrease the mortality of patients with extracorporeal membrane oxygenation in intensive care unit.pdf by Yajun Jing (11711139)

“…In multivariable analysis, even after excluding the confounding factors, such as age, APECHII score, pre-ECMO lactate, and incidence of CRRT during ECMO, the intervention bundle still can decrease the mortality independently, which also remained true in the statistical analysis of V-V and V-A ECMO separately. …”

Amplitude for A/L = 0.29. by Muhammad Hammad Bucha (21736111)

Subjects:

Amplitude for A/L = 0.338. by Muhammad Hammad Bucha (21736111)

Subjects:

Amplitude for A/L = 0.02. by Muhammad Hammad Bucha (21736111)

Subjects:

Amplitude for A/L = 0.03. by Muhammad Hammad Bucha (21736111)

Subjects:

Genetic information on 5 subjects carrying <i>NR5A1</i> mutations. by Jana Malikova (615672)

Subjects:

S5 Fig - by Meghan J. Hirsch (16528311)

Multi-way sensitivity analysis on transmission rate, CD4 count at diagnosis, and ART costs in a model-based analysis of Immediate ART initiation in Côte d’Ivoire. by Eric N. Ouattara (6890174)